Greenwich LifeSciences, Inc. - Common stock (GLSI)
25.00
+4.31 (20.83%)
NASDAQ · Last Trade: Dec 29th, 3:55 PM EST
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · December 29, 2025
The company’s Board extended the lock-up on shares held by directors, officers, and pre-IPO investors through Sept. 30, 2026.
Via Stocktwits · December 29, 2025
Let's have a look at the stocks with an unusual volume in today's session.
Via Chartmill · December 18, 2025
Greenwich LifeSciences shares surged following the company’s announcement of positive results from its phase III clinical trial, FLAMINGO-01.
Via Stocktwits · December 15, 2025

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.
Via Benzinga · March 25, 2024
Via Benzinga · September 10, 2025
Via Benzinga · May 1, 2025
Via Benzinga · April 2, 2025

Greenwich LifeSciences just reported results for the second quarter of 2024.
Via InvestorPlace · August 15, 2024

Via Benzinga · July 25, 2024

GLSI stock results show that Greenwich LifeSciences beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 20, 2024

Via Benzinga · April 22, 2024

GLSI stock results show that Greenwich LifeSciences missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · April 15, 2024

Via Benzinga · February 20, 2024

Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III clinical trial, Flamingo-01.
Via Benzinga · February 14, 2024

Via Benzinga · February 14, 2024

Via Benzinga · July 21, 2023

Although US stocks closed higher on Tuesday, there were a few notable insider trades.
Via Benzinga · January 11, 2023

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move.
Via Benzinga · October 24, 2022

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the Fintel short squeeze leaderboard.
Via Benzinga · October 17, 2022

Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.
Via Benzinga · November 25, 2022

Short-squeeze stocks continue to be a big deal for speculative traders and we're helping them out with a list to keep in mind this week!
Via InvestorPlace · October 17, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the Fintel short squeeze leaderboard.
Via Benzinga · October 10, 2022

Short squeeze stocks are still popular with speculative traders and that has us going over the top ones to keep an eye on this week!
Via InvestorPlace · October 10, 2022

Investors are still interested in short squeeze stocks lately and we've got them covered with the ones to watch this week!
Via InvestorPlace · October 3, 2022